drugset / Trial / NCT00335933

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

NCT00335933

Phase 3 Completed 378 enrolled Depomed
RandomizedFactorialDouble-blindTreatment

Summary

Gabapentin and pregabalin are treatments for some types of neuropathic pain, including postherpetic neuralgia (PHN). However, these treatments usually need to be taken 3 times a day for effective pain control. The purpose of this study is to determine whether a new gabapentin tablet, which only needs to be taken once or twice a day, is safe and effective for the treatment of postherpetic neuralgia.

Timeline

Start
2006-05
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1800 mg